Literature DB >> 30341726

Treatment of Depression in Women.

Christina Bourne1, Laura Kenkel2.   

Abstract

Women are more likely than men to experience depression throughout the life span. Sex differences in neurochemistry and brain structure, as well as societal factors may contribute to women's increased likelihood of depression. Pharmacological research targeting depression has historically excluded women, leading to a knowledge gap regarding effective antidepressant treatment in women. Antidepressant pharmacokinetics and pharmacodynamics are clearly different in men and women, necessitating a thoughtful approach to their prescription and management. Hormone changes associated with the menstrual cycle, pregnancy, and menopause also contribute to differences in depression and effective antidepressant use in women. Finally, it is important to consider potential interactions between antidepressant drugs and medications specifically used by women (oral contraceptives, tamoxifen, and estrogen).

Entities:  

Keywords:  Antidepressant; Depression; Estrogen; Hormones; Menopause; Menstrual cycle; Oral contraceptives; Postpartum; Pregnancy; Premenstrual; Sex differences; Tamoxifen; Women

Mesh:

Substances:

Year:  2019        PMID: 30341726     DOI: 10.1007/164_2018_163

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  1 in total

Review 1.  Impact of the mouse estrus cycle on cannabinoid receptor agonist-induced molecular and behavioral outcomes.

Authors:  Hye Ji J Kim; Ayat Zagzoog; Tallan Black; Sarah L Baccetto; Udoka C Ezeaka; Robert B Laprairie
Journal:  Pharmacol Res Perspect       Date:  2022-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.